Home / Sweden / CellaVision AB
CellaVision AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
12 disclosures on record
Evolution of the disclosed total
0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
July 4, 2019 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
Get the moves on CellaVision AB by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 30, 2026 | Citadel Advisors LLC | 0.59% | |
| June 26, 2026 | Citadel Advisors LLC | 0.60% | |
| June 15, 2026 | Citadel Advisors LLC | 0.50% | |
| December 17, 2019 | Bodenholm Capital AB | 0.00% | |
| September 27, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.00% | |
| September 2, 2019 | Bodenholm Capital AB | 0.53% | |
| September 1, 2019 | Bodenholm Capital AB | 0.53% | |
| August 15, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.50% | |
| August 14, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.50% | |
| August 1, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.00% | |
| July 5, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.51% | |
| July 4, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.51% |
Download 12 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 9.12% of the capital sold short
- JM AB 7.52% of the capital sold short
- Bonesupport Holding AB 6.69% of the capital sold short
- Truecaller AB 6.51% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
- Dynavox Group AB 4.57% of the capital sold short
- RaySearch Laboratories AB (publ) 4.36% of the capital sold short
- Aktiebolaget Electrolux 4.32% of the capital sold short
- AAK AB (publ) 4.23% of the capital sold short
- Mips AB 3.82% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, CellaVision AB, source Finansinspektionen, data as at July 30, 2026, https://www.quivad.com/action/cellavision-ab